Table 1.
Baseline characteristic properties of study patients and controls
ED group (n = 80) | Control group (n = 80) | P value | |
---|---|---|---|
Age (years) | 60.4 ± 11.3 | 55.4 ± 9.6 | 0.07 |
Diabetes mellitus (%) | 43 | 36 | 0.15 |
Hypertension (%) | 37 | 30 | 0.20 |
Smoke (%) | 63 | 57 | 0.35 |
Fasting blood glucose (mg/dl) | 114.4 ± 35.4 | 106.7 ± 28.8 | 0.32 |
Creatinin (mg/dl) | 0.80 ± 0.3 | 0.77 ± 0.5 | 0.10 |
Trigliseride (mg/dl) | 191.5 ± 77.8 | 185.7 ± 71.8 | 0.40 |
Total cholesterole (mg/dl) | 214.3 ± 23.5 | 209.6 ± 21.6 | 0.33 |
LDL-C (mg/dl) | 132.2 ± 18.5 | 124.3 ± 18.7 | 0.20 |
HDL-C (mg/dl) | 43.4 ± 10.2 | 46.9 ± 11.7 | 0.37 |
IGF-1 level (ng/ml) | 96.5 ± 38.3 | 132.54 ± 53.3 | <0.001* |
BMI | 29.6 ± 3.1 | 25.9 ± 2.3 | 0.001* |
ED score | 12 ± 1.2 | 23 ± 0.8 | <0.001* |
Values are means (±SD) or percentages
BMI Body mass index, ED Erectile dysfunction, HDL-C HIgh-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, IGF-1 Insulin like growth factor-1
*P < 0.05 was accepted as statistically significant